Literature DB >> 20508807

First manic episode in a 55-year-old man after initiation of aripiprazole.

Andrew Donohue1.   

Abstract

Aripiprazole is a novel antipsychotic medication that is used to treat a number of psychiatric conditions, including schizophrenia, bipolar disorder, and major depressive disorder. Although not specifically indicated for this, novel antipsychotics including aripiprazole are also used for treatment of obsessive compulsive disorder. The following case involves a 55-year-old man with refractory obsessive compulsive disorder who developed his first manic episode after taking aripiprazole. The author reviews other cases of aripiprazole-induced mania and discusses the possible pharmacodynamic mechanisms of this reaction.

Entities:  

Year:  2010        PMID: 20508807      PMCID: PMC2877620     

Source DB:  PubMed          Journal:  Psychiatry (Edgmont)        ISSN: 1550-5952


  14 in total

1.  Manic episode during treatment with aripiprazole.

Authors:  Prasad Rao Padala; Steven P Wengel; Frederick Petty
Journal:  Am J Psychiatry       Date:  2007-01       Impact factor: 18.112

2.  Investigation of the SSRI augmentation properties of 5-HT(2) receptor antagonists using in vivo microdialysis.

Authors:  Laura J Boothman; Stephen N Mitchell; Trevor Sharp
Journal:  Neuropharmacology       Date:  2006-01-23       Impact factor: 5.250

Review 3.  Practice guideline for the treatment of patients with obsessive-compulsive disorder.

Authors:  Lorrin M Koran; Gregory L Hanna; Eric Hollander; Gerald Nestadt; Helen Blair Simpson
Journal:  Am J Psychiatry       Date:  2007-07       Impact factor: 18.112

4.  The use of aripiprazole in obsessive-compulsive disorder: preliminary observations in 8 patients.

Authors:  Kathryn M Connor; Victoria M Payne; Kishore M Gadde; Wei Zhang; Jonathan R T Davidson
Journal:  J Clin Psychiatry       Date:  2005-01       Impact factor: 4.384

Review 5.  Possible induction of mania and hypomania by olanzapine or risperidone: a critical review of reported cases.

Authors:  J M Aubry; A E Simon; G Bertschy
Journal:  J Clin Psychiatry       Date:  2000-09       Impact factor: 4.384

6.  Efficacy of adjunctive aripiprazole to either valproate or lithium in bipolar mania patients partially nonresponsive to valproate/lithium monotherapy: a placebo-controlled study.

Authors:  Eduard Vieta; Caroline T'joen; Robert D McQuade; William H Carson; Ronald N Marcus; Raymond Sanchez; Randall Owen; Laurence Nameche
Journal:  Am J Psychiatry       Date:  2008-04-01       Impact factor: 18.112

7.  Efficacy and safety of aripiprazole in the treatment of bipolar disorder: a systematic review.

Authors:  Konstantinos N Fountoulakis; Eduard Vieta
Journal:  Ann Gen Psychiatry       Date:  2009-07-27       Impact factor: 3.455

8.  Aripiprazole augmentation of serotonin reuptake inhibitors in treatment-resistant obsessive-compulsive disorder: a 12-week open-label preliminary study.

Authors:  Enrico Pessina; Umberto Albert; Filippo Bogetto; Giuseppe Maina
Journal:  Int Clin Psychopharmacol       Date:  2009-09       Impact factor: 1.659

9.  Aripiprazole monotherapy for maintenance therapy in bipolar I disorder: a 100-week, double-blind study versus placebo.

Authors:  Paul E Keck; Joseph R Calabrese; Roger S McIntyre; Robert D McQuade; William H Carson; James M Eudicone; Berit X Carlson; Ronald N Marcus; Raymond Sanchez
Journal:  J Clin Psychiatry       Date:  2007-10       Impact factor: 4.384

10.  Trends in use of antipsychotics and mood stabilizers among Medicaid beneficiaries with bipolar disorder, 2001-2004.

Authors:  Colin Depp; Victoria D Ojeda; William Mastin; Jürgen Unützer; Todd P Gilmer
Journal:  Psychiatr Serv       Date:  2008-10       Impact factor: 3.084

View more
  2 in total

1.  Role of aripiprazole in treatment-resistant schizophrenia.

Authors:  Nilufar Mossaheb; Rainer M Kaufmann
Journal:  Neuropsychiatr Dis Treat       Date:  2012-05-29       Impact factor: 2.570

2.  Management of a microprolactinoma with aripiprazole in a woman with cabergoline-induced mania.

Authors:  Lisa Burback
Journal:  Endocrinol Diabetes Metab Case Rep       Date:  2015-10-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.